Published in Cancer Weekly, June 22nd, 2004
According to a study from Germany, "the aim of gene therapy includes the tight spatial and temporal control of transgenic expression. There are several approaches concerning externally inducible gene promoters used for the control of suicide genes. Two of the promoters that might play a role in head and neck cancer gene therapy are the hyperthermia-inducible human heat shock protein-70 (hsp70) promoter, as well as the radiation-inducible promoter of the early growth response-1 gene (egr-1)."
"We tested the hsp-70 promoter as well as a promoter construct containing synthetic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.